The role of IFN-γ Elispot assay in HIV vaccine research (original) (raw)

• Koup, R.A. et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650–4655 (1994).
  CAS PubMed PubMed Central Google Scholar
• Schmitz, J.E. et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283, 857–860 (1999).
  Article CAS PubMed Google Scholar
• Sáez-Cirión, A. et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. USA 104, 6776–6781 (2007).
  Article PubMed PubMed Central Google Scholar
• Jin, X. et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189, 991–998 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Borrow, P., Lewicki, H., Hahn, B.H., Shaw, G.M. & Oldstone, M.B. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103–6110 (1994).
  CAS PubMed PubMed Central Google Scholar
• Plata, F. et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 328, 348–351 (1987).
  Article CAS PubMed Google Scholar
• Walker, B.D. et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 328, 345–348 (1987).
  Article CAS PubMed Google Scholar
• Price, D.A. et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94, 1890–1895 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Allen, T.M. et al. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407, 386–390 (2000).
  Article CAS PubMed Google Scholar
• Carrington, M. & O'Brien, S.J. The influence of HLA genotype on AIDS. Annu. Rev. Med. 54, 535–551 (2003).
  Article CAS PubMed Google Scholar
• Streeck, H. et al. Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J. Virol. 81, 7725–7731 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Altfeld, M. et al. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med. 3, e403 (2006).
  Article PubMed PubMed Central Google Scholar
• Czerkinsky, C. et al. Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. J. Immunol. Methods 110, 29–36 (1988).
  Article CAS PubMed Google Scholar
• Czerkinsky, C.C., Nilsson, L.A., Nygren, H., Ouchterlony, O. & Tarkowski, A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65, 109–121 (1983).
  Article CAS PubMed Google Scholar
• Schmittel, A., Keilholz, U. & Scheibenbogen, C. Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J. Immunol. Methods 210, 167–174 (1997).
  Article CAS PubMed Google Scholar
• Sun, Y. et al. A systematic comparison of methods to measure HIV-1 specific CD8 T cells. J. Immunol. Methods 272, 23–34 (2003).
  Article CAS PubMed Google Scholar
• Hill, P.C. et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med. 4, e192 (2007).
  Article PubMed PubMed Central Google Scholar
• Kester, K.E. et al. Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naive adults at the Walter Reed Army Institute of Research. Vaccine 26, 2191–2202 (2008).
  Article CAS PubMed Google Scholar
• Pass, H.A., Schwarz, S.L., Wunderlich, J.R. & Rosenberg, S.A. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay. Cancer J. Sci. Am. 4, 316–323 (1998).
  CAS PubMed Google Scholar
• Lauer, G.M. et al. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy. J. Virol. 79, 12979–12988 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Z.Y., Okita, D.K., Howard, J. Jr. & Conti-Fine, B.M. Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis. Neurology 48, 1643–1653 (1997).
  Article CAS PubMed Google Scholar
• Frahm, N. et al. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat. Immunol. 7, 173–178 (2006).
  Article CAS PubMed Google Scholar
• Frahm, N. et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J. Virol. 78, 2187–2200 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Cox, J.H. et al. Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. AIDS Res. Hum. Retroviruses 21, 68–81 (2005).
  Article CAS PubMed Google Scholar
• Horton, H. et al. Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J. Immunol. Methods 323, 39–54 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Betts, M.R. et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107, 4781–4789 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Boulet, S. et al. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J. Immunol. Methods 320, 18–29 (2007).
  Article CAS PubMed Google Scholar
• McElrath, M.J. et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372, 1894–1905 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sekaly, R.P. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J. Exp. Med. 205, 7–12 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Streeck, H. et al. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 5, e100 (2008).
  Article PubMed PubMed Central Google Scholar
• Bailey, J.R. et al. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. J. Virol. 82, 7395–7410 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Addo, M.M. et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77, 2081–2092 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Gnann, J.W. Jr., Nelson, J.A. & Oldstone, M.B. Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J. Virol. 61, 2639–2641 (1987).
  CAS PubMed PubMed Central Google Scholar
• Addo, M.M. et al. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc. Natl. Acad. Sci. USA 98, 1781–1786 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Bihl, F.K. et al. Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti-CD3 mAb T-cell expansion and 'RecycleSpot'. J. Transl. Med. 3, 20 (2005).
  Article PubMed PubMed Central Google Scholar